4th Quarter - Report

ASSN OF MEDICAL DEVICE REPROCESSORS for ASSN OF MEDICAL DEVICE REPROCESSORS

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry.

LobbyistCovered position, as disclosed
BRANDON CHASE MATSON —
DANIEL JOSEPH VUKELICH —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Outlined cost-savings opportunities embedded in Medicare/Medicaid reimbursement programs, Accountable Care Organizations and other shared savings models for hospitals/clinicians who utilize reprocessed single-use medical devices.

LobbyistCovered position, as disclosed
BRANDON CHASE MATSON —
DANIEL JOSEPH VUKELICH —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. Initiated discussions on upcoming MDUFA reauthorization.

LobbyistCovered position, as disclosed
BRANDON CHASE MATSON —
DANIEL JOSEPH VUKELICH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.